Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.

Saved in:
Bibliographic Details
Title: Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.
Authors: Conway A; The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: a.conway@unsw.edu.au., Grebely J; The Kirby Institute, University of New South Wales, Sydney, Australia., Tillakeratne S; The Kirby Institute, University of New South Wales, Sydney, Australia., Cunningham EB; The Kirby Institute, University of New South Wales, Sydney, Australia., Munyengeterwa U; Justice Health and Forensic Mental Health Network, Sydney, Australia., Van Dyk J; The Kirby Institute, University of New South Wales, Sydney, Australia., Martinello M; The Kirby Institute, University of New South Wales, Sydney, Australia., Carson J; The Kirby Institute, University of New South Wales, Sydney, Australia., Lafferty L; The Kirby Institute, University of New South Wales, Sydney, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, Australia., Bull RA; The Kirby Institute, University of New South Wales, Sydney, Australia., Horsburgh B; The Kirby Institute, University of New South Wales, Sydney, Australia., McGrath C; Justice Health and Forensic Mental Health Network, Sydney, Australia., Brown T; Justice Health and Forensic Mental Health Network, Sydney, Australia., Treloar C; Centre for Social Research in Health, University of New South Wales, Sydney, Australia., Amin J; New South Wales Ministry of Health, Sydney, Australia; Department of Health Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW, Australia., Degenhardt L; The National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia., Applegate TL; The Kirby Institute, University of New South Wales, Sydney, Australia., Dunlop A; Drug and Alcohol Services, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia; Healthcare Transformation Research Program, Hunter Medical Research Program, Newcastle, Australia., Matthews GV; The Kirby Institute, University of New South Wales, Sydney, Australia., Dore GJ; The Kirby Institute, University of New South Wales, Sydney, Australia., Lloyd AR; The Kirby Institute, University of New South Wales, Sydney, Australia., Hajarizadeh B; The Kirby Institute, University of New South Wales, Sydney, Australia.
Source: The International journal on drug policy [Int J Drug Policy] 2026 May; Vol. 151, pp. 105234. Date of Electronic Publication: 2026 Mar 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9014759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4758 (Electronic) Linking ISSN: 09553959 NLM ISO Abbreviation: Int J Drug Policy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-4758
DOI:10.1016/j.drugpo.2026.105234